IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16INK4a expression
Keyword(s):
2008 ◽
Vol 2008
◽
pp. 149-151
Keyword(s):
1986 ◽
Vol 25
(1)
◽
pp. 82-86
Keyword(s):
2007 ◽
Vol 106
(1)
◽
pp. 170-176
◽
Keyword(s):
2002 ◽
Vol 21
(4)
◽
pp. 314-326
◽
1987 ◽
Vol 94
(7)
◽
pp. 699-703
◽
1993 ◽
Vol 12
(3)
◽
pp. 219-223
◽
2001 ◽
Vol 13
(5)
◽
pp. 394-398
◽